OncoSil Medical Ltd's market cap is currently ―. The company's EPS TTM is AU$-0.007; its P/E ratio is -1.43; OncoSil Medical Ltd is scheduled to report earnings on August 22, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 11.37M	AU$ 12.33M	AU$ 21.00M	AU$ 7.69M	AU$ 15.21M
Total Assets	AU$ 13.07M	AU$ 14.15M	AU$ 24.06M	AU$ 11.67M	AU$ 19.88M
Total Debt	AU$ 304.21K	AU$ 484.37K	AU$ 109.94K	AU$ 0.00	AU$ 0.00
Net Debt	AU$ -11.06M	AU$ -11.85M	AU$ -20.89M	AU$ -7.69M	AU$ -15.21M
Total Liabilities	AU$ 1.91M	AU$ 2.45M	AU$ 2.16M	AU$ 993.21K	AU$ 1.73M
Stockholders Equity	AU$ 11.16M	AU$ 11.70M	AU$ 21.90M	AU$ 10.68M	AU$ 18.15M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

OncoSil Medical Ltd Earnings and Revenue History

Income Statement >

OncoSil Medical Ltd Debt to Assets

Balance Sheet >

OncoSil Medical Ltd Cash Flow

Cash Flow >

OncoSil Medical Ltd Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing